EA200200169A1 - SMALL PEPTIDES AND METHODS OF DECREASING IgE REGULATION - Google Patents

SMALL PEPTIDES AND METHODS OF DECREASING IgE REGULATION

Info

Publication number
EA200200169A1
EA200200169A1 EA200200169A EA200200169A EA200200169A1 EA 200200169 A1 EA200200169 A1 EA 200200169A1 EA 200200169 A EA200200169 A EA 200200169A EA 200200169 A EA200200169 A EA 200200169A EA 200200169 A1 EA200200169 A1 EA 200200169A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
phe
small peptides
tyr
regulation
Prior art date
Application number
EA200200169A
Other languages
Russian (ru)
Inventor
Джеймс Кларджетт
Original Assignee
Хистатек, Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хистатек, Ллс filed Critical Хистатек, Ллс
Publication of EA200200169A1 publication Critical patent/EA200200169A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Описан способ понижающей регуляции уровней IgE. Способ включает в себя введение пациенту эффективного в понижающей регуляции IgE количества пептида, имеющего формулу f-Met-Leu-X, где Х выбран из группы, состоящей из Tyr, Tyr-Phe, Phe-Phe и Phe-Tyr.Международная заявка была опубликована вместе с отчетом о международном поиске.A method of down-regulating IgE levels is described. The method comprises administering to the patient an effective in down-regulation of IgE amounts of a peptide having the formula f-Met-Leu-X, where X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr. The international application has been published along with an international search report.

EA200200169A 1999-07-16 2000-07-14 SMALL PEPTIDES AND METHODS OF DECREASING IgE REGULATION EA200200169A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14453999P 1999-07-16 1999-07-16
PCT/US2000/019496 WO2001005420A1 (en) 1999-07-16 2000-07-14 Small peptides and methods for downregulation of ige

Publications (1)

Publication Number Publication Date
EA200200169A1 true EA200200169A1 (en) 2002-06-27

Family

ID=22509041

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200169A EA200200169A1 (en) 1999-07-16 2000-07-14 SMALL PEPTIDES AND METHODS OF DECREASING IgE REGULATION

Country Status (13)

Country Link
EP (1) EP1303290A4 (en)
JP (1) JP2003504412A (en)
KR (1) KR20020040750A (en)
CN (1) CN1367700A (en)
AU (1) AU6351500A (en)
BR (1) BR0012495A (en)
CA (1) CA2379323A1 (en)
EA (1) EA200200169A1 (en)
IL (1) IL147525A0 (en)
MX (1) MXPA02000531A (en)
NO (1) NO20020224L (en)
PL (1) PL352837A1 (en)
WO (1) WO2001005420A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749685A (en) * 1986-08-01 1988-06-07 Dnax Research Institute Of Molecular And Cellular Biology, Inc. Immunosuppressive peptides
DE69840851D1 (en) * 1997-11-13 2009-07-09 Mowycal Lending Llc SMALL PEPTIDES AND METHODS FOR THE TREATMENT OF ASTHMA AND IGNITION
AU1801899A (en) * 1998-12-03 2000-06-19 Histatek, Llc Small peptides and methods for treatment of asthma and inflammation
CN1348381A (en) * 1999-03-22 2002-05-08 海斯塔泰克有限责任公司 Treatment with small peptides to effect antifibrotic activity

Also Published As

Publication number Publication date
EP1303290A1 (en) 2003-04-23
CN1367700A (en) 2002-09-04
AU6351500A (en) 2001-02-05
IL147525A0 (en) 2002-08-14
NO20020224D0 (en) 2002-01-15
NO20020224L (en) 2002-03-04
CA2379323A1 (en) 2001-01-25
KR20020040750A (en) 2002-05-30
PL352837A1 (en) 2003-09-08
EP1303290A4 (en) 2004-12-08
MXPA02000531A (en) 2002-07-02
BR0012495A (en) 2002-06-11
WO2001005420A1 (en) 2001-01-25
WO2001005420A8 (en) 2001-04-12
JP2003504412A (en) 2003-02-04

Similar Documents

Publication Publication Date Title
EA200400241A1 (en) MULTIMERAL CONTRAST SUBSTANCES BASED ON PEPTIDES ARE DIRECTED TO A TARGET
DK0719340T3 (en) Cloned glutamic acid decarboxylase
DK1599216T3 (en) Method of preventing mitochondrial permeability transition
EA199800559A1 (en) Antagonists gonadotropin-releasing factor
EA199800564A1 (en) Antagonists gonadotropin-releasing factor
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
DE69533704D1 (en) BRADYKININ ANTAGONIST PEPTIDE WITH N-SUBSTITUTED GLYCINES
TR199902802T2 (en) Probucol monoesters for the treatment of cardiovascular diseases and inflammatory diseases.
WO2002080858A3 (en) Use of kpv tripeptide for dermatological disorders
ATE399177T1 (en) DERIVATIVES OF THERAPEUTIC PEPTIDES
ES2160485A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
BR0209990A (en) Effective peptides in treating tumors and other conditions requiring cell removal or destruction
ATE278710T1 (en) ANTIMICROBIAL PEPTIDES
ATE294188T1 (en) PEPTIDIC INHIBITORS OF LFA-1/ICAM-1 INTERACTION
DE69633231D1 (en) TNF-ALPHA CONVERTING ENZYME
ATE432078T1 (en) SMALL PEPTIDES AND METHODS FOR TREATING ASTHMA AND INFLAMMATION
DE68917837D1 (en) Peptide compounds.
EA200200169A1 (en) SMALL PEPTIDES AND METHODS OF DECREASING IgE REGULATION
DE602004028266D1 (en) ANGIOGENIC PEPTIDES AND ITS USES
ATE42308T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
DE69835426D1 (en) ACTIVATION OF PEPTIDES
ATE394419T1 (en) PEPTIDE ANTAGONISTS OF DP TRANSCRIPTION FACTORS
DE60015559D1 (en) SENTRIN-SPECIFIC HUMAN PROTEASE SENP1
EA200301130A1 (en) APPLICATION OF HUMAN IMMUNE DEFICIENCY VIRUS PROTECTION INHIBITORS (HIV) TO BLOCK CELL MIGRATION AND / OR INVASIUM, TISSUE INFILTRATION AND DRAIN IN THE TREATMENT OF RELATED DISEASES
EA200100477A1 (en) PHARMACEUTICAL COMPOSITION THP AND ENALAPRIL